<DOC>
	<DOCNO>NCT00512304</DOCNO>
	<brief_summary>Post-operative radio-chemotherapy decrease recurrence risk gastric cancer ( N Engl J Med 2001 ) . However chemotherapy regimen ( 5 fluorouracil IV bolus ) use toxic suboptimal . We propose evaluate adjuvant situation active well tolerate chemotherapy regimen ( FOLFIRI ) patient metastatic gastric cancer . During radiotherapy use 5 FU continue infusion previously report . The global design adjuvant treatment four FOLFIRI course , radiotherapy ( 45 Gy ) 5FU IV continue four FOLFIRI .</brief_summary>
	<brief_title>Adjuvant Treatment Gastric Cancer With Chemotherapy Chemoradiotherapy ( TRACE )</brief_title>
	<detailed_description />
	<mesh_term>Stomach Neoplasms</mesh_term>
	<criteria>gastric adenocarcinoma histologically confirm tumor T3 N+ pretherapeutic staging ( Scanner endoscopic ultrasound ) performance status WHO &lt; 2 serum albumin &gt; 30 gr/l weight loss &lt; 10 % next 6 month sign informed consent form metastatic disease prior abdominal radiotherapy</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>March 2013</verification_date>
</DOC>